1 results match your criteria: "and Centre Val d'Aurelle[Affiliation]"
J Clin Oncol
May 2001
Institut Gustave Roussy, Villejuif, Centre Léon Bérard, Lyon, and Centre Val d'Aurelle, Montpellier, France.
Purpose: To assess the value of postsurgery chemotherapy in patients with disseminated nonseminomatous germ-cell tumors (NSGCTs) and viable residual disease after first-line cisplatin-based chemotherapy.
Patients And Methods: The outcome of 238 patients was reviewed. Tumor markers had normalized in all patients before resection.